1. Home
  2. SCM vs LXEO Comparison

SCM vs LXEO Comparison

Compare SCM & LXEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCM
  • LXEO
  • Stock Information
  • Founded
  • SCM 2012
  • LXEO 2017
  • Country
  • SCM United States
  • LXEO United States
  • Employees
  • SCM N/A
  • LXEO N/A
  • Industry
  • SCM Finance/Investors Services
  • LXEO
  • Sector
  • SCM Finance
  • LXEO
  • Exchange
  • SCM Nasdaq
  • LXEO Nasdaq
  • Market Cap
  • SCM 387.3M
  • LXEO 93.9M
  • IPO Year
  • SCM 2012
  • LXEO 2023
  • Fundamental
  • Price
  • SCM $13.96
  • LXEO $4.13
  • Analyst Decision
  • SCM Hold
  • LXEO Strong Buy
  • Analyst Count
  • SCM 1
  • LXEO 5
  • Target Price
  • SCM $13.00
  • LXEO $16.60
  • AVG Volume (30 Days)
  • SCM 110.5K
  • LXEO 671.0K
  • Earning Date
  • SCM 08-06-2025
  • LXEO 08-11-2025
  • Dividend Yield
  • SCM 11.47%
  • LXEO N/A
  • EPS Growth
  • SCM 26.74
  • LXEO N/A
  • EPS
  • SCM 1.42
  • LXEO N/A
  • Revenue
  • SCM $103,691,042.00
  • LXEO N/A
  • Revenue This Year
  • SCM $0.36
  • LXEO N/A
  • Revenue Next Year
  • SCM $2.94
  • LXEO N/A
  • P/E Ratio
  • SCM $9.80
  • LXEO N/A
  • Revenue Growth
  • SCM N/A
  • LXEO N/A
  • 52 Week Low
  • SCM $11.19
  • LXEO $1.45
  • 52 Week High
  • SCM $15.56
  • LXEO $19.50
  • Technical
  • Relative Strength Index (RSI)
  • SCM 64.41
  • LXEO 58.96
  • Support Level
  • SCM $13.48
  • LXEO $3.63
  • Resistance Level
  • SCM $13.89
  • LXEO $4.50
  • Average True Range (ATR)
  • SCM 0.22
  • LXEO 0.44
  • MACD
  • SCM 0.03
  • LXEO 0.01
  • Stochastic Oscillator
  • SCM 87.86
  • LXEO 60.77

About SCM Stellus Capital Investment Corporation

Stellus Capital Investment Corp is a closed-end, non-diversified management investment company. Its objective is to maximize the total return to its stockholders in the form of current income and capital appreciation. It invests in private middle-market companies through a first lien, second lien, and unsecured debt financing, often with a corresponding equity investment. The company invests in various sectors, such as business services, energy, general industrial, government services, healthcare, software, and specialty finance. The business activity of the firm is functioned through the United States and it generates revenue in the form of interest income on debt investments and capital gains and distributions.

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healthcare by applying pioneering science to fundamentally alter how diseases are treated. The company focuses on preclinical and clinical stage gene therapies, specifically hereditary and acquired diseases with high unmet needs, which represent its sole business segment.

Share on Social Networks: